Advocates on Steps of Congress 2013
Please leave this field empty
Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #625 | Sept. 25, 2015  

¡Nuevo! Updated Spanish-Language Scleroderma Brochures

Spanish BrochuresWe recently revised several of our Spanish-language brochures. You can view some of our most popular brochure content, such as:

  • Esclerodermia: Información General y Causas (Scleroderma: General Information and Causes)
  • Esclerosis Sistémica: Difusa y Limitada (Systemic Scleroderma: Diffuse and Limited)
  • Esclerodermia Localizada (Localized Scleroderma)
  • La Hipertensión Pulmunar en la Esclerodermia (Pulmonary Hypertension in Scleroderma)
Download these brochures in Spanish or English >>

About ANA and Antibody Testing

An ANA test can detect antinuclear antibodies (ANA) in your blood. Your immune system normally makes antibodies to fight an infection. However, some people also create antinuclear antibodies, which often times can attack your body's own tissues.

Your doctor may say you need an ANA test to determine if you have an autoimmune disease, such as lupus, scleroderma or rheumatoid arthritis.

For more information, please visit sclerodermainfo.org >>

Video: Scleroderma Hands and Their Care

Video: Scleroderma Hands
In this session from the 2015 National Patient Education Conference in Nashville, Dr. Francesco Boin discusses what’s causing damage and how to take good care of your hands.

View the entire session now >>

Prescription Drug User Fee Act (PDUFA) Reauthorization Process

pill bottle.jpgThe Prescription Drug User Fee Act (PDUFA) authorizes the U.S. Food and Drug Administration (FDA) to collect fees from pharmaceutical companies to help fund the agency’s drug review work. PDUFA’s intent is to provide additional funding for FDA to hire staff, improve systems, and establish a better-managed review process that enables us to do more timely reviews of human drug applications.

As a result, many important new drug therapies have been made available to patients sooner without compromising FDA’s high standards for safety, efficacy, and quality.

Learn more about PDUFA from the FDA Blog >>

Donate Button
Quick Links
Advocacy
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Store
Home
facebook_32.png
twitter_32.png
Youtube_32x32.png

Actelion current web size
Bayer 2015 gold and platinum Sponsor
Gilead Silver Conference Sponsor
United Therapeutics corporate sponsor.jpg

 

 

Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2017 All rights reserved.